SAMe use in children and adolescents

European Child and Adolescent Psychiatry

Volumn 13, Issue 5, 2004, Pages 332-334

  Schaller, James L ^a   Thomas, John ^b   Bazzan, Anthony J ^c  

^a Newgate Center   (United States)

^b Life Counseling Services   (United States)

^c Functional Wellness Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CLOMIPRAMINE; IMIPRAMINE; OMEGA 3 FATTY ACID; PLACEBO; S ADENOSYLMETHIONINE;

ADOLESCENT; CASE REPORT; CHILD; CHILD PSYCHIATRY; DEPRESSION; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; PSYCHOPHARMACOTHERAPY; TREATMENT OUTCOME;

ADOLESCENT; CHILD; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; S-ADENOSYLMETHIONINE; TREATMENT OUTCOME;

EID: 6344268946     PISSN: 10188827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00787-004-0396-9     Document Type: Letter

References (14)

1. Cantoni GL (1952) The nature of the active methyl donor formed enzymatically from L-methionine and adenosinetriphosphate. J Am Chem Soc 74:2942-2943
2. Brown R, Bottiglieri T, Colman C (1999) Stop Depression Now: SAMe Berkly, New York, p 5
3. Agnoli A, Andreoli V, Casacchia M, Cerbo R (1976) Effect of S-adenosyl-L-methionine (SAMe) upon depressive symptoms. J Psychiatr Res 13:43-54
4. Janicak PG, Lipinski J, Davis JM, et al. (1988) S-adenosylmethionine in depression. A literature review and preliminary report. Ala J Med Sci 25:306-313
5. Knowlton L (2003) Investigating SAMe. Geriatric Times 2001; 2:no page listed. http://www.geriatrictimes.com/g010923.html. Accessed December 15
6. Silveri MM, Parow AM, Villafuerte RA, Damico KE, Goren J, Stoll AL, Cohen BM, Renshaw PF (2003) S-adenosyl-L-methionine: effects on brain bioenergetic status and transverse relaxation time in healthy subjects. Biol Psychiatry 54:833-839
7. Bottiglieri T (2002) S-Adenosyl-L-methionine (SAMe): from the bench to the bedside-molecular basis of a pleiotrophic molecule. Am J Clin Nutr 76:1151S-1157S
8. Benelli A, Filaferro M, Bertolini A, Genedani S (1999) Influence of S-adenosyl-L-methionine on chronic mild stress-induced anhedonia in castrated rats. Br J Pharmacol 127:645-654
9. Delle Chiaie R, Pancheri P, Sapicchio P (2002) Efficacy and tolerability of oral and intramuscular S-adenosyl-L-methionine 1.4-butanedisulfonate (SAMe) in the treatment of major depression: comparison with imipramine in 2 multicenter studies. Am J Clin Nutr 76:1172S-1176S
10. Pancheri P, Scapicchio P Chiaie RD (2002) A double-blind, randomized parallel-group, efficacy and safety study of intramuscular S-adenosyl-L- methionine 1.4-butanedisulphonate (SAMe) versus imipramine in patients with major depressive disorder. Int J Neuropsychopharmacol 5:287-294
11. Saletu B, Anderer P, Di Padova C, Assandri A, Saletu-Zyhlarz GM (2002) Electrophysiological neuroimaging of the central effects of S-adenosyl-L- methionine by mapping of electroencephalograms and event-related potentials and low-resolution brain electromagnetic tomography. Am J Clin Nutr 76:1162S-1171S
12. Fava M, Giannelli A, Rapisarda V, Patralia A, Guaraldi GP (1995) Rapidity of onset of the antidepressant effect of parenteral S-adenosyl-L-methionine. Psychiatry Res 56:295-297
13. Kovacs M (1985) The children's depression inventory (CDI). Psychopharmacol Bull 21:995-998
14. http://consumerlab.com/results/same.asp. Accessed December 14:2003